Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biopsy, Fine-Needle | 2 | 2018 | 50 | 1.260 |
Why?
|
| Lung Neoplasms | 6 | 2019 | 384 | 1.090 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 2018 | 7 | 0.680 |
Why?
|
| RNA, Neoplasm | 1 | 2018 | 20 | 0.680 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2019 | 93 | 0.430 |
Why?
|
| Bronchoscopy | 3 | 2018 | 56 | 0.220 |
Why?
|
| Cystatin A | 1 | 2019 | 8 | 0.170 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2019 | 10 | 0.170 |
Why?
|
| Antigens, Neoplasm | 1 | 2019 | 44 | 0.170 |
Why?
|
| Serine Endopeptidases | 1 | 2018 | 19 | 0.170 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 33 | 0.170 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 48 | 0.160 |
Why?
|
| Lymphoma | 1 | 2018 | 36 | 0.160 |
Why?
|
| Feasibility Studies | 1 | 2018 | 263 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 249 | 0.150 |
Why?
|
| Aged | 6 | 2019 | 9487 | 0.140 |
Why?
|
| Granuloma | 1 | 2016 | 13 | 0.140 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 3717 | 0.140 |
Why?
|
| Middle Aged | 6 | 2019 | 10829 | 0.130 |
Why?
|
| Lymph Nodes | 1 | 2016 | 92 | 0.130 |
Why?
|
| Cohort Studies | 1 | 2018 | 1687 | 0.120 |
Why?
|
| Quinazolines | 1 | 2013 | 31 | 0.120 |
Why?
|
| Humans | 7 | 2019 | 29093 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 587 | 0.110 |
Why?
|
| Male | 7 | 2019 | 17807 | 0.110 |
Why?
|
| Female | 6 | 2019 | 18164 | 0.110 |
Why?
|
| Adult | 3 | 2018 | 8420 | 0.100 |
Why?
|
| Neoplasms | 1 | 2016 | 610 | 0.090 |
Why?
|
| Dioxoles | 1 | 2004 | 1 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 787 | 0.060 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2004 | 50 | 0.060 |
Why?
|
| Eating | 1 | 2004 | 73 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2019 | 3111 | 0.050 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 17 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2018 | 95 | 0.040 |
Why?
|
| Decision Trees | 1 | 2018 | 23 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 142 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 436 | 0.040 |
Why?
|
| Obesity | 1 | 2004 | 1063 | 0.040 |
Why?
|
| Genotype | 1 | 2018 | 735 | 0.040 |
Why?
|
| Survival Rate | 1 | 2019 | 795 | 0.040 |
Why?
|
| Mediastinum | 1 | 2016 | 12 | 0.040 |
Why?
|
| False Negative Reactions | 1 | 2016 | 21 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 301 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2016 | 156 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 1362 | 0.030 |
Why?
|
| Filgrastim | 1 | 2013 | 4 | 0.030 |
Why?
|
| Cyclin D3 | 1 | 2013 | 4 | 0.030 |
Why?
|
| Survival | 1 | 2013 | 13 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2013 | 21 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 2019 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 2108 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2013 | 65 | 0.030 |
Why?
|
| Taxoids | 1 | 2013 | 47 | 0.030 |
Why?
|
| Cisplatin | 1 | 2013 | 69 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 77 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 281 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 248 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 246 | 0.030 |
Why?
|
| Young Adult | 1 | 2018 | 2402 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 401 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 546 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 3099 | 0.020 |
Why?
|
| Adipose Tissue, Brown | 1 | 2004 | 6 | 0.020 |
Why?
|
| Animal Feed | 1 | 2004 | 14 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2004 | 5 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 2004 | 45 | 0.020 |
Why?
|
| Ion Channels | 1 | 2004 | 24 | 0.020 |
Why?
|
| Species Specificity | 1 | 2004 | 84 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 2004 | 29 | 0.020 |
Why?
|
| Food Preferences | 1 | 2004 | 35 | 0.020 |
Why?
|
| Leptin | 1 | 2004 | 66 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2004 | 108 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2004 | 67 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2004 | 131 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 454 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2004 | 159 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 256 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2004 | 514 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2004 | 327 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 1604 | 0.010 |
Why?
|
| Animals | 1 | 2004 | 7297 | 0.010 |
Why?
|